Sonoma Pharmaceuticals, Inc. (SNOA) vs cbdMD, Inc. (YCBD)
- Sonoma Pharmaceuticals, Inc. SNOA 1.13 −1.74%
- cbdMD, Inc. YCBD 0.35 −2.78%
Sonoma Pharmaceuticals, Inc. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. Sonoma Pharmaceuticals, Inc. is the larger, with a market value of $5.5M against $4.0M — 1.4× the size. Sonoma Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; cbdMD, Inc. trades at 41.2×. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against 10.0%. Sonoma Pharmaceuticals, Inc. has the higher net margin (−10.3% vs −14.7%) and the lower return on invested capital (−70.0% vs −29.8%). Across the 17 metrics below, Sonoma Pharmaceuticals, Inc. leads on 10 and cbdMD, Inc. on 7.
Valuation
Profitability
| Metric | SNOA | YCBD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 38.91% | 57.68% | 53.94% |
| Operating margin | (6.41%) | (13.87%) | 0.00% |
| Net margin | (10.33%) | (14.71%) | 0.00% |
| Free cash flow margin | (12.11%) | (11.51%) | 0.00% |
| Return on equity | (42.52%) | (43.01%) | (0.40%) |
| Return on assets | (13.85%) | (26.73%) | (3.32%) |
| Return on invested capital | (69.96%) | (29.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack